Touchstone International Medical Science Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000042J3
CNY
42.54
-0.05 (-0.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
270.37
251.51
230.10
212.03
162.21
171.43
117.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
270.37
251.51
230.10
212.03
162.21
171.43
117.37
Raw Material Cost
119.53
117.74
105.00
96.02
73.07
74.34
52.85
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
61.70
59.99
0.00
0.00
25.19
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.38
0.19
0.27
0.07
0.10
0.49
0.51
Selling and Distribution Expenses
70.16
67.70
57.68
59.40
45.25
40.33
32.50
Other Expenses
3.38
3.35
-2.87
-3.24
1.37
1.20
-1.61
Total Expenditure (Excl Depreciation)
223.91
219.15
195.93
183.13
132.17
127.16
94.91
Operating Profit (PBDIT) excl Other Income
46.5
32.400000000000006
34.2
28.900000000000002
30
44.3
22.5
Other Income
11.08
12.43
10.95
18.38
10.13
4.19
5.22
Operating Profit (PBDIT)
67.76
53.92
52.65
54.05
46.32
53.62
31.53
Interest
0.38
0.19
0.27
0.07
0.10
0.49
0.51
Exceptional Items
-1.89
4.06
2.14
-0.64
0.56
1.03
0.00
Gross Profit (PBDT)
150.84
133.77
125.10
116.01
89.13
97.09
64.52
Depreciation
10.66
9.83
8.44
7.24
6.58
5.56
3.86
Profit Before Tax
54.83
47.95
46.08
46.09
40.20
48.60
27.16
Tax
2.94
0.64
2.89
4.67
5.25
6.59
4.03
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
51.89
47.31
43.20
41.42
34.95
42.01
23.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
51.89
47.31
43.20
41.42
34.95
42.01
23.13
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
51.89
47.31
43.20
41.42
34.95
42.01
23.13
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
581.43
571.52
508.41
512.13
465.89
107.18
82.90
Earnings per share (EPS)
0.64
0.58
0.53
0.51
0.44
0.53
0.29
Diluted Earnings per share
0.64
0.58
0.53
0.51
0.44
0.53
0.29
Operating Profit Margin (Excl OI)
17.02%
12.59%
14.45%
13.41%
18.25%
25.59%
19.13%
Gross Profit Margin
24.22%
22.97%
23.7%
25.15%
28.84%
31.59%
26.43%
PAT Margin
19.19%
18.81%
18.77%
19.53%
21.55%
24.5%
19.71%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 7.51% vs 9.30% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 9.73% vs 9.49% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 36.63% vs -0.48% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 100.00% vs -33.33% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Touchstone International Medical Science Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
270.37
0
270.37
Other Operating Income
0.00
0.00
0.00
Total Operating income
270.37
0
270.37
Raw Material Cost
119.53
0
119.53
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.38
0
0.38
Selling and Distribution Expenses
70.16
0
70.16
Other Expenses
3.38
0.00
3.38
Total Expenditure (Excl Depreciation)
223.91
0
223.91
Operating Profit (PBDIT) excl Other Income
46.45
0.00
46.45
Other Income
11.08
0
11.08
Operating Profit (PBDIT)
67.76
0
67.76
Interest
0.38
0
0.38
Exceptional Items
-1.89
0
-1.89
Gross Profit (PBDT)
150.84
0
150.84
Depreciation
10.66
0
10.66
Profit Before Tax
54.83
0
54.83
Tax
2.94
0
2.94
Provisions and contingencies
0
0
0.00
Profit After Tax
51.89
0
51.89
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
51.89
0
51.89
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
51.89
0
51.89
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
581.43
0
581.43
Earnings per share (EPS)
0.64
0
0.64
Diluted Earnings per share
0.64
0
0.64
Operating Profit Margin (Excl OI)
17.02%
0%
0.00
17.02%
Gross Profit Margin
24.22%
0%
0.00
24.22%
PAT Margin
19.19%
0%
0.00
19.19%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 27.04 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 7.51% vs 9.30% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 5.19 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 9.73% vs 9.49% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.67 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 36.63% vs -0.48% in Dec 2023

Annual - Interest
Interest 0.04 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 100.00% vs -33.33% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.02%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023